Table 1 Descriptive statistics of NHW and MA participants categorized by population and cognitive phenotype in the Texas Alzheimer’s Research and Care Consortium for buffy coat mitochondrial DNA oxidative mutational load.

From: Integrative blood-based characterization of oxidative mitochondrial DNA damage variants implicates Mexican American’s metabolic risk for developing Alzheimer’s disease

 

NC

MCI

AD

P-valuea

Total Number of Subjects

328

127

104

 

Non-Hispanic Whites

153

43

64

 

 Age [CI]

70.39 ± 1.178

71.35 ± 1.421

71.70 ± 1.056

0.338

 Sex (F) [n, %]

78, 50.98%

21, 48.84%

29, 45.31%

0.747

 Mini Mental State Exam (MMSE) [CI]

29.11 ± 0.1759

27.63 ± 0.6223

21.53 ± 1.413

< 0.001b

 Clinical Dementia Rating (CDR) Sum [CI]

0.007 ± 0.009

1.163 ± 0.2181

5.344 ± 0.8515

< 0.001c

 Years of Education [CI]

16.07 ± 0.4063

14.56 ± 0.6597

15.11 ± 0.7524

0.001d

 BMI kg/m2 [CI]

27.331 ± 1.150

27.272 ± 2.328

27.394 ± 1.062

0.996

 Diabetes (Y) [n, %]

59, 38.56%

18, 41.86%

22, 34.38%

0.723

 Hypercholesterolemia (Y) [n, %]

90, 58.82%

26, 60.47%

50, 78.13%

0.023

 Hyperlipidemia (Y) [n, %]

56, 36.60%

15, 34.88%

39, 60.94%

0.002

 Hypertension (Y) [n, %]

100, 65.36%

31, 72.09%

44, 68.75%

0.680

 Obesity (Y) [n, %]

27, 17.65%

8, 18.69%

10, 15.63%

0.910

 Depression (Y) [n, %]

12, 7.84%

6, 13.95%

17, 26.56%

0.001

 Tobacco Abuse (Y) [n, %]

51, 33.33%

18, 41.86%

28, 43.75%

0.279

 Alcohol Abuse (Y) [n, %]

3, 1.96%

5, 11.63%

3, 4.69%

0.020

Mexican Americans

175

84

40

 

 Age [CI]

67.62 ± 0.8156

69.88 ± 1.691

73.37 ± 2.485

< 0.001e

 Sex (F) [n, %]

99, 56.57%

40, 47.62%

24, 60.00%

0.302

 Mini Mental State Exam (MMSE) [CI]

28.14 ± 0.2889

24.93 ± 1.140

19.87 ± 1.860

< 0.001f

 Clinical Dementia Rating (CDR) Sum [CI]

0.006 ± 7.89710–3

1.113 ± 0.2261

5.737 ± 1.183

< 0.001g

 Years of Education [CI]

11.05 ± 0.6598

8.77 ± 1.664

9.75 ± 1.547

0.002h

 BMI kg/m2 [CI]

30.917 ± 0.9992

31.295 ± 2.228

28.717 ± 1.651

0.116

 Diabetes (Y) [n, %]

79, 45.14%

32, 38.10%

19, 47.50%

0.484

 Hypercholesterolemia (Y) [n, %]

103, 58.86%

52, 61.90%

23, 57.50%

0.862

 Hyperlipidemia (Y) [n, %]

89, 50.86%

35, 41.67%

12, 30.00%

0.120

 Hypertension (Y) [n, %]

120, 68.57%

63, 75.00%

28, 70.00%

0.567

 Obesity (Y) [n, %]

84, 48.00%

38, 45.24%

8, 20.00%

0.005

 Depression (Y) [n, %]

19, 10.86%

29, 34.52%

15, 37.50%

< 0.001

 Tobacco Abuse (Y) [n, %]

82, 46.86%

39, 46.43%

18, 45.00%

0.978

 Alcohol Abuse (Y) [n, %]

6, 3.43%

0, 0.00%

2, 5.00%

0.172

  1. NC normal control, MCI mild cognitive impairment, AD Alzheimer’s Disease.
  2. aThe mean difference is significant at 0.05.
  3. bNC vs. MCI 0.016, NC vs. AD < 0.001, MCI vs. AD < 0.001.
  4. cNC vs. MCI <0.001, NC vs. AD < 0.001, MCI vs. AD < 0.001.
  5. dNC vs. MCI 0.003, NC vs. AD 0.042, MCI vs. AD 0.542.
  6. eNC vs. MCI 0.028, NC vs. AD < 0.001, MCI vs. AD 0.017.
  7. fNC vs. MCI <0.001, NC vs. AD < 0.001, MCI vs. AD < 0.001.
  8. gNC vs. MCI <0.001, NC vs. AD < 0.001, MCI vs. AD < 0.001.
  9. hNC vs. MCI 0.001, NC vs. AD 0.273, MCI vs. AD 0.540.